Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
153 USD | +0.02% | +3.09% | +14.12% |
May. 07 | ICF International, Inc. Wins $236 Million Global Health Contract | CI |
May. 02 | ICF International Q1 Adjusted Earnings, Revenue Increase; Reaffirms 2024 Outlook | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- With a 2024 P/E ratio at 28.1 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Business Support Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+14.12% | 2.87B | A- | ||
+11.36% | 7.78B | A- | ||
-32.09% | 3.3B | - | ||
-1.85% | 1.55B | C+ | ||
-8.42% | 1.1B | - | - | |
-5.93% | 733M | - | ||
-3.86% | 604M | C+ | ||
-21.11% | 525M | - | - | |
-14.32% | 509M | - | ||
-14.92% | 484M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ICFI Stock
- Ratings ICF International, Inc.